Discordance between predicted postoperative forced expiratory volumes in one second (ppoFEV1) calculated before and after resection of bronchogenic carcinoma

Interactive Cardiovascular and Thoracic Surgery

Volumn 2, Issue 2, 2003, Pages 138-142

  Varela, Gonzalo ^a   Jiménez, Marcelo F ^a   Novoa, Nuria ^a   Macrí, Paolo ^a  

^a HOSPITAL UNIVERSITARIO DE SALAMANCA   (Spain)

Author keywords

Lung carcinoma; Predicted postoperative pulmonary function; Pulmonary resection; Risk prediction

Indexed keywords

CALCULATION; CANCER LOCALIZATION; CANCER PATIENT; CANCER SURGERY; CONTROLLED STUDY; CORRELATION ANALYSIS; EVALUATION; FORCED EXPIRATORY VOLUME; HUMAN; LOBECTOMY; LUNG CARCINOMA; LUNG RESECTION; MAJOR CLINICAL STUDY; MULTIPLE REGRESSION; POSTOPERATIVE PERIOD; PREDICTION; PREOPERATIVE PERIOD; PRIORITY JOURNAL; PROSPECTIVE STUDY; REVIEW; SURGICAL TECHNIQUE; TUMOR CLASSIFICATION;

EID: 1542714645     PISSN: 15699293     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1569-9293(02)00121-4     Document Type: Review

References (15)

1. Kuller L.H., Ockene J., Meilahn E., Svendsen K.H. Relation of forced expiratory volume in one second (FEV1) to lung cancer mortality in the multiple risk factor intervention trial. Am J Epidemiol. 132:1990;265-274.
2. Kearney D.J., Lee T.H., Reilly J.J., DeCamp M.M., Sugarbaker D.J. Assessment of operative risk in patients undergoing lung resection. Importance of predicted pulmonary function. Chest. 105:1994;753-759.
3. Reilly J.J. Evidence-based preoperative evaluation of candidates for thoracotomy. Chest. 116:1999;474S-476S.
4. Licker M., de Perrot M., Hohn L., Tschopp J.M., Robert J., Frey J.G., Schweizer A., Spiliopoulos A. Perioperative mortality and major cardio-pulmonary complications after lung surgery for non-small cell carcinoma. Eur J Cardiothorac Surg. 15:1999;314-319.
5. Lopez Pujol J., Alvarez Kindelan A., Algar Algar J., Cerezo Madueño F., López Rivero L., Salvatierra Velásquez A. Perioperative morbimortality in pneumonectomy. Analysis of risk factors. Arch Bronconeumol. 36:2000;251-256.
6. Alexiou C., Beggs D., Rogers M.L., Beggs L., Asopa S., Salama F.D. Pneumonectomy for non-small cell lung cancer: predictors of perioperative mortality and survival. Eur J Cardiothorac Surg. 20:2001;476-480.
7. Bernard A., Deschamps C., Allen M.S., Miller D.L., Trastek V.F., Jenkins G.D., Pairolero P.C. Pneumonectomy for malignant disease: factors affecting early morbidity and mortality. J Thorac Cardiovasc Surg. 121:2001;1076-1082.
8. Ferguson M.K., Karrison T. Does pneumonectomy for lung cancer adversely influence long-term survival? J Thorac Cardiovasc Surg. 119:2000;440-448.
9. Mizushima Y., Noto H., Sugiyama S., Kusajima Y., Yamashita R., Kashii T., Kobayashi M. Survival and prognosis after pneumonectomy for lung cancer in the elderly. Ann Thorac Surg. 64:1997;193-198.
10. Okada M., Tsubota N., Yoshimura M., Miyamoto Y., Matsuoka H., Satake S., Yamagishi H. Extended sleeve lobectomy for lung cancer: the avoidance of pneumonectomy. J Thorac Cardiovasc Surg. 118:1999;710-713.
11. Martin-Ucar A.E., Chaudhuri N., Edwards J.G., Waller D.A. Can pneumonectomy for non-small cell lung cancer be avoided? An audit of parenchymal sparing lung surgery. Eur J Cardiothorac Surg. 21:2002;601-605.
12. Lausberg H.F., Graeter T.P., Wendler O., Demertzis S., Ukena D., Schäfers H.J. Bronchial and bronchovascular sleeve resection for treatment of central lung tumors. Ann Thorac Surg. 70:2000;367-371.
13. Foroulis C.N., Kotoulas C., Konstantinou M., Lioulias A. Is the reduction of forced expiratory lung volume proportional to the lung parenchyma resection 6 months after pneumonectomy? Eur J Cardiothorac Surg. 21:2002;901-905.
14. Bronchogenic Cooperative Group of the Spanish Society of Pneumology and Thoracic Surgery, Lopez-Encuentra A., Gomez de la Cámara A. Validation of a central review board of staging prior to surgery for non-small cell lung cancer-impact on prognosis: a multicenter study. Respiration. 69:2002;16-24.
15. Takizawa T., Terashima M., Koike T., Akamatsu H., Kurita Y., Yokoyama A. Mediastinal lymph-node metastasis in patients with clinical stage I peripheral non-small-cell lung cancer. J Thorac Cardiovasc Surg. 113:1997;248-252.